Glucotrack Inc (GCTK)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Glucotrack Inc Stock (GCTK) Company Profile

Glucotrack Inc

Healthcare (1087)

972 (8) 675-7878

301 RT 17 NORTH, RUTHERFORD

Nächster Verdiensttermin

Neueste SEC-Einreichungen

GCTK's Discussions on Twitter

Compare GCTK vs ISRG, BDX, ALC, RMD, MDLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GCTK Glucotrack Inc	2.99	2.34M	0	-16.89M	-16.44M	-20.88
ISRG Intuitive Surgical Inc	353.20	123.70B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	180.17	48.78B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	69.04	33.41B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	219.25	31.89B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	34.76	30.44B	29.14B	1.07B	1.05B	1.1956

Glucotrack Inc Aktie (GCTK) Neueste Nachrichten

Finanzdaten der Glucotrack Inc-Aktie (GCTK)

Glucotrack Inc (GCTK)

Glucotrack Inc Stock (GCTK) Company Profile

Compare GCTK vs ISRG, BDX, ALC, RMD, MDLN

Glucotrack Inc Aktie (GCTK) Neueste Nachrichten

Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - kalkinemedia.com

Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - 01net

GlucoTrack Inc (GCTK) Key Financial Ratios – Valuation, Profitability & More - Value Research

Glucotrack (NASDAQ: GCTK) Announces White Lion Capital's 9.99% Stake Comprising 79,734 Shares - kalkinemedia.com

GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research

Near-10% Glucotrack (GCTK) holder faces ~5% cap unless limits raised - Stock Titan

Lōkahi Therapeutics Expands Ai2 Futures Lab Asset Origination Network Through Collaboration With San Diego State University Fowler College of Business - Moomoo

What Is Driving Glucotrack Stock? (NASDAQ:GCTK) - Kalkine Media

GlucoTrack Inc (GCTK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Glucotrack (NASDAQ: GCTK) Executes 1-for-15 Reverse Stock Split, Reducing Shares to About 798,144 - kalkinemedia.com

What Is Driving Glucotrack Stock? - Kalkine Media

Glucotrack (GCTK) adds Lokahi merger statements and pro forma results - stocktitan.net

Glucotrack (NASDAQ: GCTK) reveals 90% Lokahi stake and going-concern warning - Stock Titan

GlucoTrack Announces 1-for-15 Reverse Stock Split - The Globe and Mail

Glucotrack Sets 1-for-15 Reverse Stock Split to Address Nasdaq Requirement - citybiz

Glucotrack announces 1-for-15 reverse split to reduce shares, CUSIP update, Nasdaq compliance goal - tradingview.com

Glucotrack to implement 1-for-15 reverse stock split Monday By Investing.com - Investing.com Nigeria

Glucotrack to implement 1-for-15 reverse stock split Monday - Investing.com

Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100 - Yahoo Finance

Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia - marketscreener.com

Form 8K GlucoTrack Inc For: 19 August By Investing.com - Investing.com Nigeria

Glucotrack shareholders approve director elections, reverse split, and warrant inducement - Investing.com

Glucotrack Shareholders Approve Up to 1-for-30 Reverse Stock Split - Minichart

Glucotrack (NASDAQ: GCTK) investors back reverse split, warrant deal - Stock Titan

Glucotrack, Inc. Approves the Election of Erik Emerson and Paul V. Goode to the Board of Directors - marketscreener.com

GlucoTrack Stock Short Interest Rises to 33.15% - Quiver Quantitative

GlucoTrack, Inc. (GCTK) Latest Stock News & Headlines - Yahoo Finance

Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances - Yahoo Finance

Glucotrack regains Nasdaq compliance on equity requirement By Investing.com - Investing.com Canada

Glucotrack regains Nasdaq compliance on equity requirement - Investing.com

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Business Wire

Glucotrack Company Profile & Introduction - Moomoo

Glucotrack Inc. (GCTK) narrows loss, warns on going concern and closes Lokahi deal - Stock Titan

GlucoTrack, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

GCTK|GlucoTrack Inc|Price:0.367|Chg%:+0.002 - TradingKey

GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

GlucoTrack Amends Equity Financing and Issues Commitment Shares - TipRanks

GlucoTrack Inc (GCTK) Stock News Today - tradingkey.com

GlucoTrack Secures New Financing to Support Growth - The Globe and Mail

Glucotrack Raises $5.5M as It Settles Into Its New Identity as an AI-Driven Biopharma Platform - biobuzz.io

E.F. Hutton Advises on $5.5 Million Financing for Glucotrack Subsidiary Lōkahi Therapeutics - citybiz

E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack - The Manila Times

Glucotrack Secures $5.5 Million Financing With Premium Equity and Institutional Investment to Boost Growth - Minichart

Glucotrack Raises $5.5 Million Through Bridge Follow-On and Interim PIPE, Adds Registration Rights - TradingView

GlucoTrack, Inc. announced that it expects to receive $5.5 million in funding - marketscreener.com

Glucotrack Secures $5.5 Million Financing to Support Growth Strategy and Product Development - citybiz

Glucotrack Announces $5.5 Million Financing - marketscreener.com

Lōkahi Therapeutics Ai2 Futures Lab Changes How Biopharma Builds a Pipeline - 富途牛牛

Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline - marketscreener.com

Glucotrack (GCTK) asks shareholders to approve $50M ELOC and convertible financing - Stock Titan

Finanzdaten der Glucotrack Inc-Aktie (GCTK)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie GCTK